Leqembi offers hope for Alzheimer’s patients, but access to treatment remains difficult
The new Alzheimer’s drug Leqembi is being hailed as a significant advance in the fight against this debilitating disease, promising to extend the quality of life for those affected. However, patients face significant barriers to accessing this promising treatment. Leqembi, developed by Biogen and Eisai, is designed to slow the progression of Alzheimer’s by targeting…